Law Firm Launches Investigation into Baldwin, Lifecore, and Pacira Transactions
Halper Sadeh LLC is scrutinizing the terms of sale for Baldwin Group, Lifecore Biomedical, and Pacira BioSciences to determine if shareholder interests were prioritized.
New York-based law firm Halper Sadeh LLC has launched an investigation into potential securities law violations and breaches of fiduciary duty regarding three separate corporate transactions. The review concerns the pending sales of Baldwin Group, Inc., Lifecore Biomedical, Inc., and Pacira BioSciences, Inc.
The firm is examining whether the boards of these companies secured fair value for shareholders during negotiations. Specifically, investigators are looking into the sale of Baldwin Group for $32.50 per share, the $6.28 per share deal for Lifecore Biomedical, and Viatris Inc.’s $36.50 per share acquisition of Pacira BioSciences.
Key areas of focus include whether the agreements contain terms that unfairly limit competing offers and if insiders received preferential treatment. Halper Sadeh is evaluating whether legal action is required to secure additional disclosures or enhanced compensation for investors affected by these deals.